Protein Description

Gene Symbol DAB2
Entrez ID 1601
Uniprot ID P98082
Description Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
Chromosomal Location chr5: 39,371,675-39,462,300
Ontology GO ID GO Term Definition Evidence

BP

GO:0001934

positive regulation of protein phosphorylation

Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.

IMP

BP

GO:0006898

receptor-mediated endocytosis

An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.

IEA

BP

GO:0006915

apoptotic process

A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.

IEA

BP

GO:0007275

multicellular organism development

The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).

IEA

BP

GO:0008283

cell proliferation

The multiplication or reproduction of cells, resulting in the expansion of a cell population.

TAS

BP

GO:0010718

positive regulation of epithelial to mesenchymal transition

Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.

IDA

BP

GO:0010862

positive regulation of pathway-restricted SMAD protein phosphorylation

Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.

IDA

BP

GO:0015031

protein transport

The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IEA

BP

GO:0016055

Wnt signaling pathway

The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.

IEA

BP

GO:0030335

positive regulation of cell migration

Any process that activates or increases the frequency, rate or extent of cell migration.

IMP

BP

GO:0030511

positive regulation of transforming growth factor beta receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.

IDA

BP

GO:0032091

negative regulation of protein binding

Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.

IMP

BP

GO:0032436

positive regulation of proteasomal ubiquitin-dependent protein catabolic process

Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

IMP

BP

GO:0035026

leading edge cell differentiation

The process in which relatively unspecialized cells acquire specialized structural and/or functional features of leading edge cells, cells at the front of a migrating epithelial sheet.

IMP

BP

GO:0043066

negative regulation of apoptotic process

Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.

IDA

BP

GO:0045807

positive regulation of endocytosis

Any process that activates or increases the frequency, rate or extent of endocytosis.

IMP

BP

GO:0045892

negative regulation of transcription, DNA-templated

Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.

IMP

BP

GO:0045893

positive regulation of transcription, DNA-templated

Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.

IMP

BP

GO:0060391

positive regulation of SMAD protein import into nucleus

Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.

IDA

BP

GO:0060766

negative regulation of androgen receptor signaling pathway

Any process that decreases the rate, frequency, or extent of the androgen receptor signaling pathway.

IMP

BP

GO:0090090

negative regulation of canonical Wnt signaling pathway

Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.

IMP|ISS

BP

GO:1903077

negative regulation of protein localization to plasma membrane

Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.

IMP

BP

GO:2000096

positive regulation of Wnt signaling pathway, planar cell polarity pathway

Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.

IMP

BP

GO:2000370

positive regulation of clathrin-dependent endocytosis

Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.

IMP

BP

GO:2000643

positive regulation of early endosome to late endosome transport

Any process that activates or increases the frequency, rate or extent of early endosome to late endosome transport.

IMP

CC

GO:0005730

nucleolus

A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.

IDA

CC

GO:0005765

lysosomal membrane

The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.

TAS

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

IDA|TAS

CC

GO:0005905

clathrin-coated pit

A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.

IDA

CC

GO:0005925

focal adhesion

Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.

IDA

CC

GO:0030136

clathrin-coated vesicle

A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.

IDA

CC

GO:0030665

clathrin-coated vesicle membrane

The lipid bilayer surrounding a clathrin-coated vesicle.

IEA

CC

GO:0043231

intracellular membrane-bounded organelle

Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.

IDA

CC

GO:0070022

transforming growth factor beta receptor homodimeric complex

A homodimeric receptor complex that consists of two TGF-beta receptor monomers.

IDA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008022

protein C-terminus binding

Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.

IPI

MF

GO:0035615

clathrin adaptor activity

The binding activity of a molecule that brings together clathrin and one or more other molecules, permitting them to function in a coordinated way.

IMP

MF

GO:0038024

cargo receptor activity

Combining selectively with an extracellular substance and delivering the substance into the cell via endocytosis.

IMP

MF

GO:0046332

SMAD binding

Interacting selectively and non-covalently with a SMAD signaling protein.

IDA

Domain ID Description

IPR006020

PTB/PI domain

IPR011993

PH domain-like

Pathway ID Pathway Term Pathway Source

hsa04144

Endocytosis

KEGG

WP366

TGF-beta Signaling Pathway

WikiPathways

WP2853

Endoderm Differentiation

WikiPathways

UMLS CUI UMLS Term

C0346647

Malignant Neoplasm Of Pancreas

C1561643

Chronic Kidney Diseases

Tissue Cell Type

kidney

cells in tubules

placenta

trophoblastic cells

No databases found.

Pubmed ID Author Year Title

15598877

Wood et al.

2005

Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects

22904171

Kaur et al.

2012

Differential Gene Expression in Granulosa Cells from Polycystic Ovary Syndrome Patients with and without Insulin Resistance: Identification of Susceptibility Gene Sets through Network Analysis

Gene Symbol Entrez ID Uniprot ID Score

AXIN1

8312

O15169

0.56

ITGB3

3690

P05106

0.59

ITGB5

3693

P18084

0.59

ACTB

60

P60709

0.63

AP2A1

160

O95782

0.63

AP2B1

163

P63010

0.63

AHCY

191

P23526

0.63

CCNT1

904

O60563

0.63

FYN

2534

P06241

0.63

HNRNPL

3191

P14866

0.63

HSPA1A

3303

P0DMV8

0.63

HSPA1B

3304

P0DMV9

0.63

PRDX1

5052

Q06830

0.63

PIK3R1

5295

P27986

0.63

PYCR1

5831

P32322

0.63

SOD1

6647

P00441

0.63

AURKA

6790

O14965

0.63

TRIO

7204

O75962

0.63

CDC16

8881

Q13042

0.63

NUP155

9631

O75694

0.63

SEC24B

10427

O95487

0.63

SEC23B

10483

Q15437

0.63

HSPH1

10808

Q92598

0.63

MALT1

10892

Q9UDY8

0.63

SF3B2

10992

Q13435

0.63

CPSF6

11052

Q16630

0.63

ACOT9

23597

Q9Y305

0.63

C14orf166

51637

Q9Y224

0.63

YLPM1

56252

P49750

0.63

CPSF7

79869

Q8N684

0.63

ATXN1L

342371

P0C7T5

0.63

JUN

3725

P05412

0.68

MAPK8

5599

P45983

0.68

FCHO2

115548

Q0JRZ9

0.68

APLP1

333

P51693

0.75

APLP2

334

Q06481

0.75

APP

351

P05067

0.75

DVL1

1855

O14640

0.75

INPP5D

3635

Q92835

0.75

LDLR

3949

P01130

0.75

LRP1

4035

Q07954

0.75

AP2M1

1173

Q96CW1

0.76

DVL2

1856

O14641

0.78

DAB2IP

153090

Q5VWQ8

0.78

CLTC

1213

Q00610

0.82

SH3KBP1

30011

Q96B97

0.82

FGR

2268

P09769

0.85

TGFBR1

7046

P36897

0.86

TGFBR2

7048

P37173

0.87

CSK

1445

P41240

0.88

GRB2

2885

P62993

0.88

LRP2

4036

P98164

0.89

PIN1

5300

Q13526

0.89

SRC

6714

P12931

0.89

MYO6

4646

Q9UM54

0.90

LRP6

4040

O75581

0.19

PRRT2

112476

Q7Z6L0

0.52

PRKCB

5579

P05771

0.55

PRKCD

5580

Q05655

0.55

PRKCG

5582

P05129

0.55

ANXA1

301

P04083

0.63

EPS15

2060

P42566

0.63

NCK1

4690

P16333

0.63

ITSN1

6453

Q15811

0.63

TFAP2A

7020

P05549

0.63

XPO1

7514

O14980

0.63

SLC25A41

284427

Q8N5S1

0.63

CDK1

983

P06493

0.65

CAPZA2

830

P47755

0.72

CLTB

1212

P09497

0.72

DBN1

1627

Q16643

0.72

FLNA

2316

P21333

0.72

FN1

2335

P02751

0.72

GAK

2580

O14976

0.72

MYH9

4627

P35579

0.72

PPP1CB

5500

P62140

0.72

PICALM

8301

Q13492

0.72

IQGAP1

8826

P46940

0.72

ACTR2

10097

P61160

0.72

SYNPO

11346

Q8N3V7

0.72

MAPRE1

22919

Q15691

0.72

LIMA1

51474

Q9UHB6

0.72

GTSE1

51512

Q9NYZ3

0.72

ANLN

54443

Q9NQW6

0.72

MYO19

80179

Q96H55

0.72

MYO18A

399687

Q92614

0.72

SMURF2

64750

Q9HAU4

0.73

MIB1

57534

Q86YT6

0.77

DIP2A

23181

Q14689

0.78

CFTR

1080

P13569

0.82

AP2A2

161

O94973

0.83

SMAD2

4087

Q15796

0.89

DVL3

1857

Q92997

0.90

SMAD3

4088

P84022

0.90